Published in J Biol Chem on October 06, 2014
Glycogen metabolism in humans. BBA Clin (2016) 0.95
Personalized biochemistry and biophysics. Biochemistry (2015) 0.88
The Effect of Weight Loss on the Muscle Proteome in the Damara, Dorper and Australian Merino Ovine Breeds. PLoS One (2016) 0.77
Molecular basis of classic galactosemia from the structure of human galactose 1-phosphate uridylyltransferase. Hum Mol Genet (2016) 0.76
Data on the phosphorylation state of the catalytic serine of enzymes in the α-D-phosphohexomutase superfamily. Data Brief (2016) 0.75
Identification of potential genes for human ischemic cardiomyopathy based on RNA-Seq data. Oncotarget (2016) 0.75
Multiple phenotypes in phosphoglucomutase 1 deficiency. N Engl J Med (2014) 2.62
Gene identification in the congenital disorders of glycosylation type I by whole-exome sequencing. Hum Mol Genet (2012) 1.90
Protein misfolding is the molecular mechanism underlying MCADD identified in newborn screening. Hum Mol Genet (2009) 1.76
Evolutionary trace analysis of the alpha-D-phosphohexomutase superfamily. Protein Sci (2004) 1.32
Reaction mechanism of phosphoglucosamine mutase from Escherichia coli. Eur J Biochem (1999) 1.22
Rescue of cystathionine beta-synthase (CBS) mutants with chemical chaperones: purification and characterization of eight CBS mutant enzymes. J Biol Chem (2010) 1.20
Protein misfolding disorders: pathogenesis and intervention. J Inherit Metab Dis (2006) 1.17
Muscle glycogenosis due to phosphoglucomutase 1 deficiency. N Engl J Med (2009) 1.10
A phylogenetic approach to the identification of phosphoglucomutase genes. Mol Biol Evol (1998) 1.02
A novel congenital disorder of glycosylation type without central nervous system involvement caused by mutations in the phosphoglucomutase 1 gene. J Inherit Metab Dis (2012) 0.98
A kinetic study of the isozymes determined by the three human phosphoglucomutase loci PGM1, PGM2, and PGM3. Eur J Biochem (1974) 0.98
Regulation of phosphoglucomutase 1 phosphorylation and activity by a signaling kinase. Oncogene (2004) 0.98
Pharmacological chaperones as therapeutics for lysosomal storage diseases. J Med Chem (2013) 0.98
New strategies for the treatment of lysosomal storage diseases (review). Int J Mol Med (2012) 0.96
Galactose supplementation in phosphoglucomutase-1 deficiency; review and outlook for a novel treatable CDG. Mol Genet Metab (2014) 0.96
Expression analysis revealing destabilizing mutations in phosphomannomutase 2 deficiency (PMM2-CDG): expression analysis of PMM2-CDG mutations. J Inherit Metab Dis (2011) 0.95
Structure of rabbit muscle phosphoglucomutase refined at 2.4 A resolution. Acta Crystallogr D Biol Crystallogr (1997) 0.93
Characterization of phenylketonuria missense substitutions, distant from the phenylalanine hydroxylase active site, illustrates a paradigm for mechanism and potential modulation of phenotype. Mol Genet Metab (2000) 0.93
Innovative strategies to treat protein misfolding in inborn errors of metabolism: pharmacological chaperones and proteostasis regulators. J Inherit Metab Dis (2014) 0.92
Expression analysis of phenylketonuria mutations. Effect on folding and stability of the phenylalanine hydroxylase protein. J Biol Chem (2000) 0.91
Promotion of enzyme flexibility by dephosphorylation and coupling to the catalytic mechanism of a phosphohexomutase. J Biol Chem (2014) 0.86
Phenylketonuria as a protein misfolding disease: The mutation pG46S in phenylalanine hydroxylase promotes self-association and fibril formation. Biochim Biophys Acta (2010) 0.86
Characterization of vanadate-based transition-state-analogue complexes of phosphoglucomutase by spectral and NMR techniques. Biochemistry (1990) 0.86
The classical human phosphoglucomutase (PGM1) isozyme polymorphism is generated by intragenic recombination. Proc Natl Acad Sci U S A (1993) 0.85
Mutations in hereditary phosphoglucomutase 1 deficiency map to key regions of enzyme structure and function. J Inherit Metab Dis (2014) 0.84
Comparison between medium-chain acyl-CoA dehydrogenase mutant proteins overexpressed in bacterial and mammalian cells. Hum Mutat (1995) 0.84
Phosphoglucomutase genetic polymorphism and body mass. Am J Med Sci (2007) 0.81
The relative activities attributable to the three phosphoglucomutase loci (PGM1, PGM2, PGM3) in human tissues. Ann Hum Genet (1970) 0.80
Pharmacological chaperones as a potential therapeutic option in methylmalonic aciduria cblB type. Hum Mol Genet (2013) 0.79
Intragenic recombination at the human phosphoglucomutase 1 locus: predictions fulfilled. Proc Natl Acad Sci U S A (1993) 0.79
Glycogen storage disease-like phenotype with central nervous system involvement in a PGM1-CDG patient. Neuro Endocrinol Lett (2014) 0.78
Birth weight and parental PGM1 alleles. Am J Hum Biol (2001) 0.78